SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001209191-23-052944
Filing Date
2023-10-17
Accepted
2023-10-17 16:05:28
Documents
1
Effectiveness Date
2023-10-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11223
  Complete submission text file 0001209191-23-052944.txt   12431
Mailing Address 30 BROADWICK STREET LONDON X0 W1F 8LX
Business Address 30 BROADWICK STREET LONDON X0 W1F 8LX 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-495026 | Film No.: 231329652
SIC: 2835 In Vitro & In Vivo Diagnostic Substances